Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-α
- 1 August 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (3) , 394-399
- https://doi.org/10.1038/bjc.1996.371
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Transcriptional regulation during the mammalian cell cycleTrends in Genetics, 1995
- Down‐regulation of mitochondrial gene expression by the anti‐tumor arotinoid mofarotene (Ro 40‐8757)International Journal of Cancer, 1994
- The anti‐tumor arotinoid RO 40‐8757 protects bone marrow from the toxic effects of 5‐fluorouracilInternational Journal of Cancer, 1994
- The anti‐tumor arotinoid RO 40‐8757 protects bone marrow from the toxic effects of cyclophosphamideInternational Journal of Cancer, 1993
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral IsotretinoinNew England Journal of Medicine, 1988
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- ETRETINATE IN TREATMENT OF ACTINIC KERATOSISThe Lancet, 1982